Penumbra Inc. (PEN) exhibits 67.1% gross margins and 10.6% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 52.0x enterprise multiple and 4.8% implied options volatility.
Sustained 67.1% gross profitability converts into 13.5% operating margin and 10.6% ROIC, outpacing sector cost of capital.
ROIC: 10.6% // GM: 67.1%YoY revenue trajectory of +17.5% paired with 1.38% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +17.5% // FCF YLD: 1.38%Altman Z-Score of 21.05 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 21.05 // F-SCORE: 9/9Trading at 71.4x trailing P/E (60.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 71.4x // EV/EBITDA: 52.0xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $318.95 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 12.7% net margins.
NET MARGIN: 12.7% // D/E: 0.12x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for PEN & activate live FRED threshold breach alerts.